Nasdaq
NAMS
NewAmsterdam Pharma Company N.V.
- Health Care
- Netherlands
- 1 day
- +0.9%
- 1 month
- −25.2%
- 1 year
- +17.1%
$27.67 · Mkt cap $3.23B
At the 6 Aug 2026 close
Nasdaq
NewAmsterdam Pharma Company N.V.
$27.67 · Mkt cap $3.23B
At the 6 Aug 2026 close
NewAmsterdam Pharma Company N.V. trades under the ticker NAMS on Nasdaq, in the Health Care sector (Biotechnology: Pharmaceutical Preparations). Its market capitalisation is $3.23B. The last closing price was $27.67, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +17.1%, and −25.2% over the past month. Returns are price returns and exclude dividends.
This page exists because NAMS is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.